Alpha 2.0
Login Register
» Articles » PMID: 33062948

SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience

Overview
Journal Hemasphere
Publisher Wiley
Specialty Hematology
Date 2020 Oct 16
PMID 33062948
Citations 6
Authors
Sandra Mossuto
Enrico Attardi
Francesco Alesiani
Emanuele Angelucci
Enrico Balleari
Massimo Bernardi
Gianni Binotto
Costanza Bosi
Anna Calvisi
Isabella Capodanno
Antonella Carbone
Andrea Castelli
Marco Cerrano
Rosanna Ciancia
Daniela Cilloni
Marino Clavio
Cristina Clissa
Elena Crisa
Monica Crugnola
Matteo G Della Porta
Nicola Di Renzo
Ambra Di Veroli
Roberto Fattizzo
Carmen Fava
Susanna Fenu
Ida L Ferrara
Luana Fianchi
Carla Fili
Carlo Finelli
Valentina Giai
Francesco Frattini
Valentina Gaidano
Gianluca Guaragna
Svitlana Gumenyuk
Roberto Latagliata
Stefano Mancini
Emanuela Messa
Alfredo Molteni
Pellegrino Musto
Pasquale Niscola
Esther Oliva
Giuseppe A Palumbo
Annamaria Pelizzari
Federica Pilo
Antonella Poloni
Marta Riva
Flavia Rivellini
Chiara Sarlo
Mariarita Sciume
Roberto Secchi
Carmine Selleri
Agostino Tafuri
Valeria Santini
Affiliations
Soon will be listed here.
Citing Articles

Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients.

De Novellis D, Folliero V, Giudice V, Pezzullo L, Sanna G, Fontana R Clin Exp Med. 2023; 23(8):4943-4953.

PMID: 37898572 PMC: 10725343. DOI: 10.1007/s10238-023-01223-w.

Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis.

Carrara E, Razzaboni E, Azzini A, De Rui M, Pinho Guedes M, Gorska A Hematol Oncol. 2022; 41(1):16-25.

PMID: 36238977 PMC: 9874549. DOI: 10.1002/hon.3084.

Incidence of symptomatic Covid-19 infections in patients with mastocytosis and chronic myeloid leukemia: A comparison with the general Austrian population.

Graf I, Herndlhofer S, Kundi M, Greiner G, Sperr M, Hadzijusufovic E Eur J Haematol. 2022; 110(1):67-76.

PMID: 36193973 PMC: 9874474. DOI: 10.1111/ejh.13875.

COVID-19 in Patients with Hematologic Malignancies: Clinical Manifestations, Persistence, and Immune Response.

Gur I, Giladi A, Isenberg Y, Neuberger A, Stern A Acta Haematol. 2022; 145(3):297-309.

PMID: 35235928 PMC: 9254311. DOI: 10.1159/000523872.

COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments.

Martinez J, Sica R, Stockerl-Goldstein K, Rubinstein S Acta Haematol. 2022; 145(3):244-256.

PMID: 35134811 PMC: 9059013. DOI: 10.1159/000522436.

References
1.
Nachtkamp K, Stark R, Strupp C, Kundgen A, Giagounidis A, Aul C . Causes of death in 2877 patients with myelodysplastic syndromes. Ann Hematol. 2016; 95(6):937-44. DOI: 10.1007/s00277-016-2649-3. View
2.
Silzle T, Blum S, Schuler E, Kaivers J, Rudelius M, Hildebrandt B . Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients. Blood Cancer J. 2019; 9(8):63. PMC: 6689049. DOI: 10.1038/s41408-019-0223-7. View
3.
Latagliata R, Niscola P, Fianchi L, Aloe Spiriti M, Maurillo L, Carmosino I . Pulmonary infections in patients with myelodysplastic syndromes receiving frontline azacytidine treatment. Hematol Oncol. 2020; 38(2):189-196. DOI: 10.1002/hon.2710. View
4.
Dayyani F, Conley A, Strom S, Stevenson W, Cortes J, Borthakur G . Cause of death in patients with lower-risk myelodysplastic syndrome. Cancer. 2010; 116(9):2174-9. PMC: 3753205. DOI: 10.1002/cncr.24984. View
5.
Motta I, Migone De Amicis M, Pinto V, Balocco M, Longo F, Bonetti F . SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience. Am J Hematol. 2020; 95(8):E198-E199. PMC: 7264660. DOI: 10.1002/ajh.25840. View